Intelligence Platform

Patents

Browse 25 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12377068

In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pe

Provectus Pharmatech, Inc. · Granted Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133840

Halogenated xanthene composition and method for treating hematologic cancers

Provectus Pharmatech, Inc. · Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12064507

Composition and method for oral treatment of leukemia

Provectus Pharmatech, Inc. · Granted Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11974980

In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pe

Provectus Pharmatech, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11975106

Uses of halogenated xanthenes in oncology and virology

Provectus Pharmatech, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11938182

Halogenated xanthenes as vaccine adjuvants

Provectus Pharmatech, Inc. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11426379

Combination of local and systemic therapies for enhanced treatment of dermatologic conditi

Provectus Pharmatech, Inc. · Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11419844

Halogenated xanthene composition and method for treating hematologic cancers

Provectus Pharmatech, Inc. · Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11071781

Combination of local and systemic immunomodulative therapies for enhanced treatment of can

Provectus Pharmatech, Inc. · Granted Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11058664

In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pe

Provectus Pharmatech, Inc. · Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10471144

Combination of local rose bengal and systemic immunomodulative therapies for enhanced trea

Provectus Pharmatech, Inc. · Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10130658

Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a smal

Provectus Pharmatech, Inc. · Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9839688

Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment

Provectus Pharmatech, Inc. · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808524

Combination of local and systemic immunomodulative therapies for melanoma and liver cancer

Provectus Pharmatech, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422260

Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-

Provectus Pharmatech, Inc. · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8974363

Topical medicaments and methods for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557298

Medicaments for chemotherapeutic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470296

Intracorporeal medicaments for high energy phototherapeutic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863047

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7648695

Medicaments for chemotherapeutic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427389

Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes

Provectus Pharmatech, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7402299

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7390668

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7384623

High energy phototherapeutic agents

Provectus Pharmatech, Inc. · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted